Sustained virological response rates with direct-acting antivirals in black subjects with HCV genotype 1 infection: systematic analysis of clinical trials

Sustained virological response rates with direct-acting antivirals in black subjects with HCV genotype 1 infection: systematic analysis of clinical trials

Objectives: Under representation of black subjects in trials of hepatitis C virus (HCV) direct-acting antivirals (DAAs) complicates assessment of differential outcomes for black individuals vs non-black individuals. HCV trials submitted to the Food and Drug Administration (2013–2017) to support appr...

Full description

Bibliographic Details
Main Authors: Kimberly Struble, Kirk Chan-Tack, Karen Qi, Thamban Valappil, Sarah Connelly, Poonam Mishra, Dionne Price, Jeffrey Murray, Debra Birnkrant
Format: Article
Language:English
Published: Elsevier 2019-07-01
Series:Journal of Virus Eradication
Subjects:
hepatitis C
clinical trial
Food and Drug Administration
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664020300431

Internet

http://www.sciencedirect.com/science/article/pii/S2055664020300431

Similar Items